Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

nintedanib

- PMLiVE

HCA names new chief executive

Anneliese Cameron will take over from Julia Cook in January

- PMLiVE

Boehringer/Lilly’s Jardiance approved in US

But the FDA wants four post-marketing studies of the SGLT-2 diabetes drug

PMCPA looks to app to simplify the APBI Code of Practice

Code regulator takes 'digitally-led' approach in partnership with The Earthworks

ABPI London offices

ABPI and BIA to support understanding of biosimilars

Trade bodies work together on communication materials for prescribers

Boehringer continues award-winning ChatAFib tweet chat

Its next social media discussion follows the programme's Communiqué win

Boehringer Ingelheim headquarters

Boehringer submits COPD combo in EU

Combines Spiriva and Striverdi

- PMLiVE

ADA: Lilly/Boehringer insulin glargine matches Lantus

Biosimilar demonstrates equal efficacy to Sanofi’s big-selling diabetes treatment

- PMLiVE

Boehringer aims for nintedanib approval in lung fibrosis by year end

EMA grants accelerated assessment to drug in rare disease

- PMLiVE

UK pharma’s ‘controversial’ new pharmacist compliance rules

As the changes take effect CompliMed's Dr Rina Newton says they look to be a practical step forward

- PMLiVE

Boehringer launches ASCO blog to talk about lung cancer

Not Just One Disease set to cover a range of topics, including the patient journey

- PMLiVE

ABPI appoints value and access manager

Christine Rowland joins from Pfizer

- PMLiVE

The changing regulatory environment

Code of practice changes are encouraging transparency in pharma/HCP relationships

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links